baber/WOPTO huggingface dataset:
Patent DK-1425244-T3 (DK)
Inventor: MAHLENDORF FALKO
IPC: H01M8/06
Filed: 2002-08-22
Granted: 2007-08-27
Abstract: The invention relates to a compact steam reformer which generates a hydrogen-rich product gas from hydrocarbons or hydrocarbon derivatives with heat recapture from the reformate, and to a process for producing the hydrogen-containing product gas. The product gas may, for example, be used in a cell to generate current and heat.
Patent DK-1572074-T3 (DK)
Inventor: SOKOLL KENNETH K
IPC: A61P33/00
Filed: 2003-02-14
Granted: 2012-05-07
Abstract: The present invention provides an immunostimulatory complex specifically adapted to act as adjuvant and as a peptide immunogen stabilizer. The immunostimulatory complex comprises a CpG oligonucleotide and a biologically active peptide immunogen. The immunostimulatory complex is particulate and can efficiently present peptide immunogens to the cells of the immune system to produce an immune response. The immunostimulatory complex may be formulated as a suspension for parenteral administration. The immunostimulatory complex may also be formulated in the form of w/o-emulsions or in-situ gelling polymers for the efficient delivery of immunogens to the cells of the immune system of a subject following parenteral administration, to produce an immune response.
Patent DK-1499360-T3 (DK)
Inventor: WATTS PETER JAMES
IPC: A61P27/16
Filed: 2003-03-19
Granted: 2009-02-09
Abstract: Aqueous formulations suitable for intranasal administration comprise buprenorphine or a physiologically acceptable salt or ester thereof and (a) a pectin having a degree of esterification of less than 50%, (b) chitosan and a polyoxyethylene-polyoxypropylene copolymer (poloxamer) or (c) chitosan and hydroxypropylmethylcellulose. Such formulations can induce rapid and prolonged analgesia when delivered intranasally to a patient. The buprenorphine or buprenorphine salt or ester may be delivered to the bloodstream to produce within 30 minutes a therapeutic plasma concentration of buprenorphine, C ther , of 0.2 ng/ml or greater which is maintained for a duration T maint  of at least 2 hours.
Patent DK-1485345-T3 (DK)
Inventor: STEINMETZER TORSTEN
IPC: A61P35/00
Filed: 2003-03-11
Granted: 2008-11-03
Abstract: The invention relates to novel inhibitors of urokinase and to their preparation and use for the therapy, prophylaxis and diagnosis of a tumor, in particular for reducing the formation of tumor metastases.
Patent DK-1454568-T3 (DK)
Inventor: ELZENBECK MANFRED
IPC: A47C1/025
Filed: 2004-03-02
Granted: 2008-10-27
Abstract: The chair is equipped with a seat carrying construction assembled of a swivel mounted front (6) and rear part. The seat can be adjusted regarding its level of inclination with a spring (27, 28), adjustable in length and swivel mounted between front (6) and rear part. The distance between the spring (27, 28) and the swivel axle is controlled with a rotating handle (42). The handle (42) is joined with a coupling element (39,40) designed as a bevel gear unit to the control device (36) resulting of the axles of the handle (42) and the control device (36) forming an angle.
Patent DK-1638948-T3 (DK)
Inventor: DAHL BJARNE H
IPC: A61P19/00
Filed: 2004-06-15
Granted: 2009-02-02
Abstract: The present invention relates to novel diphenylurea derivatives useful as chloride channel blockers. In other aspects the invention relates to the use of these compounds in a method for therapy, and to pharmaceutical compositions comprising the compounds of the invention.
Patent DK-1667666-T3 (DK)
Inventor: CRIERE BRUNO
IPC: A61K9/16
Filed: 2004-10-01
Granted: 2009-06-22
Abstract: The invention is related to the use of a composition of fenofibrate containing micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant, said composition containing an amount of fenofibrate greater than or equal to 60% by weight, for the preparation of a medicament for treating hypertriglyceridemias, hypercholesterolemias or hyperlipidemias while reducing the food effect on the bioävailability of fenofibrate. The invention is also related to an immediate release composition in the form of granules comprising : (a) a neutral core; (b) an active layer, wich surrounds the core; and (c)an outer layer; wherein said active layer comprises micronized fenofibrate, a surfactant and a binding cellulose derivative; and wherein said composition has a dissolution profile of less than 10% at 5 minutes and more than 80% at 20 minutes according to the European Pharmacopoeia in a dissolution medium constituted by water with 0.025 M sodium lauryl sulfate.
Patent DK-1796490-T3 (DK)
Inventor: LAMBERTZ BODO W
IPC: A41B11/00
Filed: 2005-08-17
Granted: 2010-02-15
Abstract: A sock for use in athletic activities comprises at least one substantially rod-shaped pad ( 3 ) in the area of the ankle region of the sock. In preferred embodiments, the sock includes at least two such rod-shaped-pads, which are preferably of different lengths and arranged essentially parallel to one another. Preferably, air channels ( 25 ) are provided on at least one surface of the sock (e.g. made from a climate regulating knit mesh fabric). In other embodiments the sock includes at least one climate channel ( 26 ) is in the tread area ( 13 ) of the sock.
Patent DK-1656952-T3 (DK)
Inventor: RUNKEL LAURA
IPC: A61K47/50
Filed: 1999-10-15
Granted: 2014-01-20
Abstract: An interferon beta polypeptide comprising interferon-beta 1a coupled to a polymer containing a polyalkylene glycol moiety wherein the interferon-beta-1a and the polyalkylene glycol moiety are arranged such that the interferon-beta-1a has an enhanced activity relative to another therapeutic form of interferon beta (interferon-beta-1b) and exhibits no decrease in activity as compared to non-conjugated interferon-beta-1a. The conjugates of the invention are usefully employed in therapeutic as well as non-therapeutic, e.g., diagnostic, applications.
Patent DK-1883400-T3 (DK)
Inventor: LANCESSEUR DIDIER
IPC: A61K9/48
Filed: 2006-05-17
Granted: 2009-02-09
Abstract: The subject matter of the invention is a capsule, in particular for the packaging of inhalation formulations, in which at least one cavity is enclosed by a wall, characterized in that at least one portion of the wall has a polymer composition that contains at least one adsorbent, as well as said capsule's preferred use. Furthermore an inhaler and secondary packaging containing at least one such capsule are also described.
Patent DK-1955918-T3 (DK)
Inventor: KEMPER ANDREAS
IPC: B61D15/06
Filed: 2007-02-08
Granted: 2009-08-17
Abstract: The coupler (1) has a coupling head and a coupling rod (90) that is connected with the coupling head. A fastening plate (50) is fastened to a lower frame of a vehicle. A linear drive (30) is provided for axial displacement of the rod relative to the plate. A bearing bracket includes a bearing bracket part (60), at which a coupling head-sided end of a deformation pie (41) is fitted, and another bearing bracket part (70), at which a vehicle-sided end of the coupling rod is guided. The part (70) is axially displaceable by a linear drive relative to the part (60).
Patent DK-1970310-T3 (DK)
Inventor: FINK BERNHARD
IPC: B65B9/20
Filed: 2007-03-16
Granted: 2010-03-08
Abstract: The method for producing a tubular bag (1) for packaging of foods, comprises forming a plane web of a three-fold foil over a shaping shoulder and by a longitudinal weld seam (4) for a tube, which extends itself in the supply direction of the tube, filling bulk material in longitudinal section of the tube, and separating upper- and lower side of the longitudinal section as filled bag of the supplied covering material. The foil has a heat shrinkable layer, which is arranged to microwave-sensitive material, so that the foil is formed during the admission of microwaves in pre-determined manner. The method for producing a tubular bag (1) for packaging of foods, comprises forming a plane web of a three-fold foil over a shaping shoulder and by a longitudinal weld seam (4) for a tube, which extends itself in the supply direction of the tube, filling bulk material in a longitudinal section of the tube, and separating upper- and lower side of the longitudinal section as filled bag of the supplied covering material. The foil has a heat shrinkable layer, which is arranged to a microwave-sensitive material, so that the foil is formed during the admission of microwaves in pre-determined manner. The longitudinal section is closed by a lateral weld seam. The heat shrinkable layer, the microwave-sensitive material and if necessary a passive layer of the foil connected with the heat shrinkable layer are intended, so that a line pattern (12) is formed by the heat shrinkable layer and intended at the tubular bag during the microwave admission. The line pattern has lines extending itself parallel to each other at the covering material. An individual line of the line pattern is intended parallel to the longitudinal weld seam, so that the lines are distributedly arranged on the circumference of the bag. The individual line of the line pattern is intended parallel to the lateral weld seam, so that the lines are consecutively arranged on every longitudinal section to be formed in the supply direction of the tube. A distortion wedge is formed from several foil layers at opposite-lying ends of every side walls. The foil layers are connected with one another. No microwave-sensitive material is intended at a base section present between the side walls. The tube is formed with a triangular base surface in sectional view transverse to the supply direction of the foil. The longitudinal weld seam is intended in the area of a spike in the cross-sectional form. The line pattern is intended over the entire wall sections reaching up to the spike. The lines of the pattern are composed by alternating line sections. The microwave-sensitive material is arranged between the heat shrinkable layer and the passive layer. Contributed orientations run transverse to the individual lines in the heat shrinkable layer through horizontal bars. Independent claims are included for: (1) a foil for producing a tubular bag; and (2) a tubular bag.
Patent DK-2416798-T3 (DK)
Inventor: RODEN RICHARD B S
IPC: C07K14/025
Filed: 2010-04-12
Granted: 2018-01-08
Abstract: This invention relates, e.g., to a virus-like particle (VLP) composition assembled from a chimeric polypeptide comprising a papilloma virus (e.g., human papillomavirus, or HPV) L1 major capsid protein, into which is inserted a surface-displayed peptide comprising a neutralizing epitope of a papillomavirus L2 protein. Vaccine compositions comprising the VLP are described, as well as methods for inducing an immune response (e.g., vaccinating) a subject against papilloma virus, using the VLP, and kits comprising the VLP, for carrying out a method of the invention.
Patent DK-2887953-T3 (DK)
Inventor: CHETLAPALLI SATYA SRINIVAS
IPC: A61K38/15
Filed: 2013-08-22
Granted: 2018-01-15
Abstract: The present invention disclose a lyophilized pharmaceutical formulation comprising antibacterial agent, daptomycin as active and tocopheryl phosphate hydrolysate mixture with improved reconstitution time for parental administration and to the process of preparation thereof. Daptomycin is a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyi-L-tryptophyl-Dasparaginyl-L-aspartyi-L-threonylglŷ D,-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanines 1-lactone.
Patent DK-3077354-T3 (DK)
Inventor: LEVACHER VINCENT
IPC: C07C309/73
Filed: 2014-12-04
Granted: 2018-02-26
Abstract: The invention relates to a method for the industrial synthesis of the compound of formula (I).
Patent DK-0533667-T3 (DK)
Inventor: SCHINITSKY MICHAEL R
IPC: A61K8/00
Filed: 1990-05-25
Granted: 1995-11-13
Abstract: The depth of wrinkles in skin (caused by intrinsic or photo-induced ageing) is reduced by topical applicn. of a compsn. comprising 20-20 % ascorbic acid (I), 1-10% tyrosine (II), and 0.5-5 % of a non-toxic Zn salt (III) in a non-toxic carrier. Comprises the applicn. of the compsn. once or twice a day. The prefd. (III) is ZnSO4. Prefd. compsns. contain 5-15% (I), 3-8% (II), and 1-2% ZnSO4.
Patent DK-0482050-T3 (DK)
Inventor: BAJWA ANWAR
IPC: H04W72/04
Filed: 1990-07-11
Granted: 1996-07-29
Abstract: A cellular radio system is described in which each of these base sites of a three base site cluster has three base stations each serving a cell having a pair of sectors. Each cell shares at least some time slots of TDMA communication allocated to the cell between the two sectors, so that time slots can be assigned to the sectors of the cell on the basis of demand.
Patent DK-0485496-T3 (DK)
Inventor: DAVID COLIN MICHAEL
IPC: B05C5/00
Filed: 1990-08-03
Granted: 1993-10-18
Abstract: PCT No. PCT/GB90/01221 Sec. 371 Date Jan. 14, 1992 Sec. 102(e) Date Jan. 14, 1992 PCT Filed Aug. 3, 1990 PCT Pub. No. WO91/01812 PCT Pub. Date Feb. 21, 1991.Apparatus for dispensing includes a cartridge holder and main body having a generally circular central portion with three perpendicular flanges extending from one side and an elongate portion extending from the other side. A drive means on the elongate portion mounts a U-shaped drive rod for axial movement. Each flange includes a slot for receiving a pin formed on a replaceable generally cylindrical cartridge to act as a bayonet fitting. Viscous material is expelled from the held cartridge by driving the rod axially. A nozzle attachment has a primary section connected to the exit of the cartridge and includes a secondary section for holding a replaceable hardener tube, with the hardener being expelled by axial movement of a portion of the rod. The nozzle attachment includes a planar end surface for simple cleaning.
Patent DK-0439601-T3 (DK)
Inventor: GIRARD MARC
IPC: C12N15/49
Filed: 1990-08-17
Granted: 1994-06-13
Abstract: A composition which combines, in particular in the form of at least one hybrid molecule, or within one, at least one immunogenic peptide containing a B epitope stemming from the $i(env) glycoprotein of a pathogenic immune deficiency virus, of an HTLVI or HTLVII virus, and at least one T epitope stemming from a protein which is different from the $i(env) glycoprotein of the same immune deficiency virus, HTLVI or HTLVII, or from a corresponding protein of an immune deficiency virus other than HTLVI or HTLVII. Vaccine compositions comprising these hybrid molecules are also described. Recombinant DNAs and RNAs coding for these molecules as well as for epitopes T and B are also provided.
Patent DK-0502068-T3 (DK)
Inventor: WOLFE JESSE D
IPC: C23C14/10
Filed: 1990-11-07
Granted: 1995-06-19
Abstract: A method of depositing thin films of silicon based compounds, particularly silicon dioxide, by cathode reactive sputtering utilizes a rotating cylindrical magnetron driven by a d.c. potential. The result is a technique of forming a uniform film on large substrates with high deposition rates. Arcing normally associated with sputtering troublesome dielectric coatings such as silicon oxides is substantially eliminated.
Patent DK-0523189-T3 (DK)
Inventor: FELGNER PHILIP L
IPC: A61K48/00
Filed: 1991-04-18
Granted: 1999-12-13
Abstract: Disclosed are cationic lipids capable of facilitating transport of biologically active agents into cells, including the transfection of cells by therapeutic polynucleotides, the delivery of antiviral drugs, and the introduction of immunogenic peptides. The cationic lipids, comprising an ammonium group, have the general structure    <IMAGE>  (I)  Also disclosed are adducts of these compounds comprising additional cationic sites that enhance the transfective or transport activity. Structure-activity correlations provide for the selection of preferred compounds to be synthesized for this purpose. Compositions disclosed for use of these cationic lipid include formulations for in vitro transfection and pharmaceutical formulations for parenteral and topical administration of therapeutic agents.
Patent DK-0509228-T3 (DK)
Inventor: SCHUETZ UDO
IPC: B65D19/06
Filed: 1992-03-10
Granted: 1997-03-17
Abstract: The palette-container (101) for liquids has an exchangeable plastic inner container (102), an outer shell (106) of lattice work and a palette (109) which is constructed as a bottom tray (110) and receives the bottom (111) of the inner container with positive fit, said bottom being constructed as a drainage bottom and having a filling nozzle (103) and an emptying nozzle (115) with a removal tap (105). Reinforcing beads (118a, 118b) are moulded into the bottom tray (110) which is adapted to the inclination of the drainage bottom (111), the bases (119) of the said reinforcing beads lying in a common horizontal plane (120-120). The flat bottom tray (110) has an outer support edge (117) extending downwards and is riveted or welded to a flat sub-base (121) or a sheet metal underframe in the region of the reinforcing beads (118a, 118b) and of the support edge (117) to form a hollow bottom with closed and/or open chambers (123) and a peripheral, outer, hollow support collar (124). 
<??>Due to the use of a flat bottom tray which receives the plastic inner container and has a flat sub-base or sheet metal underframe having hollow chambers and an outer, peripheral, hollow support collar, the palette is distinguished by a good damping capability and a high rigidity both in the case of oscillation loading due to gush oscillations of the liquid product in the container and due to oscillations transmitted by the transport vehicle and in the case of jolting and impact loading. 
<IMAGE>
Patent DK-0529212-T3 (DK)
Inventor: HOBURG ALBRECHT DR
IPC: A23G4/06
Filed: 1992-06-04
Granted: 1995-12-18
Abstract: The present invention describes a chewing gum composition, a process for the production thereof and its use. The chewing gum composition contains 0.01 to 5 % by weight of a water-soluble potassium salt, 1 to 5 % by weight of a phosphate and at least 50 % by weight of xylitol or xylitol and sorbitol in addition to ingredients conventional for chewing gum compositions. The chewing gum composition according to the invention can be used in particular as a dental hygiene means.
Patent DK-0576700-T3 (DK)
Inventor: PFANNENMUELLER GERHARD
IPC: H04R25/00
Filed: 1992-06-29
Granted: 1996-06-03
Abstract: In a hearing aid having a microphone (2), an amplifier device, a receiver (9) and a battery (16) as source for an operating voltage (UB), a switched-mode amplifier (8) as output stage and a triangular-voltage generator (5) as base signal generator for a pulse-duration-modulated signal, via which the switched-mode amplifier (8) is controllable, the triangular-voltage generator (5) exhibiting at least one integrator (10), the direction of integration of which is reversible in dependence on an input signal (I), the quotient of the operating voltage (UB) and of the quest value of the triangular voltage of the generator (5) is to remain at least largely constant with a varying operating voltage (UB). For this purpose, the integrator (10) is effectively connected at the input end to a switching means (12) and at the output end to a comparison circuit (14), the comparison circuit (14) controlling the switching means (12) in dependence on at least one threshold voltage derived from the operating voltage (UB), by means of which switching means the integrator (10) can be supplied with the input signal (I). <IMAGE>
Patent DK-0577634-T3 (DK)
Inventor: HOLMBERG YNGVE
IPC: B65D25/36
Filed: 1992-03-16
Granted: 1995-04-24
Abstract: The present invention relates to a packaging container consisting of two or more layers such as plastics or carton or only plastics. The packaging container is characterized in that the different layers are kept together substantially only through mechanical attachment to each other. The attachment includes that wartlike protrusions (4) have been made in the inner part (2) which cooperate with holes (3) in the outer part (1) and that overhangs (5) which form grooves (7) have been made in the inner part in which the outer part (1) fits.
Patent DK-0564643-T3 (DK)
Inventor: LE DISERT YVES
IPC: C09D167/02
Filed: 1992-10-21
Granted: 1996-09-02
Abstract: PCT No. PCT/FR92/00988 Sec. 371 Date Jun. 23, 1993 Sec. 102(e) Date Jun. 23, 1993 PCT Filed Oct. 21, 1991 PCT Pub. No. WO93/08157 PCT Pub. Date Apr. 29, 1993.Product obtained from the reaction of (a) an amine-diol resulting from the reaction of a primary amine having the formula R-NH2 in which R represents an aliphatic or aromatic radical, with at least one alkylene oxide comprising predominantly propylene oxide, and (b) at least one polyfunctional substance, capable of acting on the hydroxyl groups of said amine-diol. The product disclosed may be used as an additive in an electrodeposition paint composition in order to furnish, after application to a metal substrate, a coating or film having an improved resistance to pinholes and to cratering.
Patent DK-0579159-T3 (DK)
Inventor: JAKOBSON GERALD DR
IPC: C09D7/45
Filed: 1993-07-13
Granted: 1998-02-09
Abstract: Prodn. of polyglycerol fatty acid ester mixts. is effected by reacting a polyglycerol component (I) with a fatty acid component (II) in the presence of a catalyst using a (I):(II) molar ratio of 0.3:1.5 to 1.5:0.5. The reaction is effected by heating at 140 deg.C, pref. 145 deg.C (sic); reducing the pressure to 600 mbar, pref. 500 mbar (sic); heating to 140-220 (pref. 145-190) deg.C using a stepwise or continuous heating programme; and reducing the pressure to 10-600 (pref. 20-500) mbar using a stepwise or continuous evacuation programme. Water is distd. off continuously. When the acid no. falls below 3, the prod. is cooled and opt. worked up and/or purified. (I) comprises (by wt.): 0.1-20% glycerol (G1), 20-35% diglycerol (G2), 30-40% triglycerol and 5-49.9% tetra- and higher polyglycerols (G4+). (II) comprises one or more satd. 8-18C fatty acids and has an unsatd. fatty acid content of 0-15 wt.%. Also claimed is a polyglycerol fatty acid ester mixt. comprising (by wt.): 0.1-20% G1 esters, 20-35% G2 esters, 30-40% G3 esters and 5-49.9% C4+ esters, where the fatty acid component is as above and the mixt. comprises 20-80% monoesters, 20-80% diesters, 0-15% tri- and higher esters and less than 5% free polyglycerol. Also claimed is a liq. thickener with skin-care properties, and an o/w emulsifier with skin-care properties for use in creams or ointments, both comprising an ester mixt. as defined above and produced by the above process.
Patent DK-0662948-T3 (DK)
Inventor: GIORDANI ANTONIO
IPC: A61P43/00
Filed: 1994-07-12
Granted: 1999-06-21
Abstract: Use in the prevention and/or in the treatment of neurodegenerative diseases of 2-amino-4-phenyl-4-oxo-butyric acid derivatives which act as kynureninase enzyme inhibitors and/or kynurenine-3-hydroxylase enzyme inhibitors. Several of these derivatives are new and, as such, constitute a further object of this invention, together with the process for their preparation and the pharmaceutical compositions containing them.
Patent DK-0728001-T3 (DK)
Inventor: VERE HODGE RICHARD ANTHONY
IPC: A61K31/52
Filed: 1994-11-08
Granted: 2002-04-15
Abstract: The use of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of HHV-6 infection.
Patent DK-0730554-T3 (DK)
Inventor: BAKX MARTINUS
IPC: B65D71/00
Filed: 1994-12-14
Granted: 1999-06-28
Abstract: A top gripping carrier (11) packaging necked articles such as bottles (B) comprises top (18, 28), side (20, 26) and bottom (22, 24) walls, neck receiving apertures (38) and article retaining means (60) disposed intermediate the bottom and top wall adapted to retain the top of the associated article (B) within the carrier obscured from view from above and from the sides of the carton.